.avif)
.avif)
Biomarin Pharmaceutical Email Format
Biotechnology Research
・
1,001-2,500 employees
・
San Rafael, CA, USA
BioMarin Pharmaceutical is a global biotechnology company dedicated to developing and commercializing targeted therapies for rare genetic diseases through genetic discovery.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@bmrn.com
Company Overview
Industry
Biotechnology Research
Founded
1997
Headquarters
San Rafael, CA, USA
Revenue
$2.5B-$5B
FUNDING Stage
Public
Website
Key Executives
Alexander Hardy (President and Chief Executive Officer), Brian R. Mueller (Executive Vice President, Chief Financial Officer), C. Greg Guyer (Executive Vice President, Chief Technical Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Biomarin Pharmaceutical?
Biomarin Pharmaceutical uses the first.last format, so Jane Smith would be jane.smith@bmrn.com.
What are Biomarin Pharmaceutical's key commercial products in 2026?
Biomarin Pharmaceutical's commercial portfolio includes VOXZOGO for achondroplasia, PALYNZIQ for PKU, and enzyme therapies such as VIMIZIM, NAGLAZYME, and BRINEURA, plus GALAFOLD and POMBILITI plus OPFOLDA added through the Amicus Therapeutics acquisition.
Where does Biomarin Pharmaceutical focus its research pipeline in 2026?
Biomarin Pharmaceutical's pipeline spans skeletal conditions, enzyme therapies, and innovation programs, with late-stage candidates including BMN 351 for Duchenne muscular dystrophy and BMN 401 for ENPP1 deficiency, targeting genetically defined rare diseases.
How many employees does Biomarin Pharmaceutical have in 2026?
Biomarin Pharmaceutical has approximately 3,164 employees. Tools like Clay can help you identify and verify the right contacts within the company for outreach or prospecting.
Who leads Biomarin Pharmaceutical as CEO?
Alexander Hardy serves as President and Chief Executive Officer of Biomarin Pharmaceutical, with Brian R. Mueller as Chief Financial Officer and C. Greg Guyer as Chief Technical Officer rounding out the executive leadership team.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating